Cyclohexanol
Star0
Identification
- Generic Name
- Cyclohexanol
- DrugBank Accession Number
- DB03703
- Background
Monohydroxy derivatives of cyclohexanes that contain the general formula R-C6H11O. They have a camphorlike odor and are used in making soaps, insecticides, germicides, dry cleaning, and plasticizers. [PubChem]
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 100.1589
Monoisotopic: 100.088815006 - Chemical Formula
- C6H12O
- Synonyms
- Not Available
- External IDs
- NSC-403656
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UAlcohol dehydrogenase 1B Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as cyclohexanols. These are compounds containing an alcohol group attached to a cyclohexane ring.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Alcohols and polyols
- Direct Parent
- Cyclohexanols
- Alternative Parents
- Cyclic alcohols and derivatives / Hydrocarbon derivatives
- Substituents
- Aliphatic homomonocyclic compound / Cyclic alcohol / Cyclohexanol / Hydrocarbon derivative
- Molecular Framework
- Aliphatic homomonocyclic compounds
- External Descriptors
- secondary alcohol, cyclohexanols (CHEBI:18099) / a small molecule (CYCLOHEXANOL)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 8E7S519M3P
- CAS number
- 108-93-0
- InChI Key
- HPXRVTGHNJAIIH-UHFFFAOYSA-N
- InChI
- InChI=1S/C6H12O/c7-6-4-2-1-3-5-6/h6-7H,1-5H2
- IUPAC Name
- cyclohexanol
- SMILES
- OC1CCCCC1
References
- Synthesis Reference
Raymond J. Duggan, "Process for preparing cyclohexanone from cyclohexanol." U.S. Patent US3974221, issued June, 1942.
US3974221- General References
- Not Available
- External Links
- KEGG Compound
- C00854
- PubChem Compound
- 7966
- PubChem Substance
- 46504858
- ChemSpider
- 7678
- BindingDB
- 5
- 2099711
- ChEBI
- 18099
- ChEMBL
- CHEMBL32010
- ZINC
- ZINC000001532765
- PDBe Ligand
- CXL
- Wikipedia
- Cyclohexanol
- PDB Entries
- 1hdx / 4j62
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) 25.4 °C PhysProp boiling point (°C) 160.8 °C PhysProp water solubility 4.2E+004 mg/L (at 10 °C) FISHER,WB & VANPEPPEN,JF (1978) logP 1.23 HANSCH,C ET AL. (1995) logS -0.44 ADME Research, USCD - Predicted Properties
Property Value Source Water Solubility 17.2 mg/mL ALOGPS logP 1.35 ALOGPS logP 1.28 Chemaxon logS -0.77 ALOGPS pKa (Strongest Acidic) 18.18 Chemaxon pKa (Strongest Basic) -1.4 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 20.23 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 29.28 m3·mol-1 Chemaxon Polarizability 11.94 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9849 Blood Brain Barrier + 0.9311 Caco-2 permeable + 0.7422 P-glycoprotein substrate Non-substrate 0.7388 P-glycoprotein inhibitor I Non-inhibitor 0.9508 P-glycoprotein inhibitor II Non-inhibitor 0.9814 Renal organic cation transporter Non-inhibitor 0.8171 CYP450 2C9 substrate Non-substrate 0.8143 CYP450 2D6 substrate Non-substrate 0.8694 CYP450 3A4 substrate Non-substrate 0.6684 CYP450 1A2 substrate Non-inhibitor 0.866 CYP450 2C9 inhibitor Non-inhibitor 0.9136 CYP450 2D6 inhibitor Non-inhibitor 0.961 CYP450 2C19 inhibitor Non-inhibitor 0.9434 CYP450 3A4 inhibitor Non-inhibitor 0.9819 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9599 Ames test Non AMES toxic 0.9393 Carcinogenicity Non-carcinogens 0.8926 Biodegradation Ready biodegradable 0.7208 Rat acute toxicity 1.8237 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7564 hERG inhibition (predictor II) Non-inhibitor 0.9174
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 114.4880618 predictedDarkChem Lite v0.1.0 [M-H]- 114.5228618 predictedDarkChem Lite v0.1.0 [M-H]- 126.709175 predictedDeepCCS 1.0 (2019) [M+H]+ 115.7066618 predictedDarkChem Lite v0.1.0 [M+H]+ 115.5021618 predictedDarkChem Lite v0.1.0 [M+H]+ 128.73247 predictedDeepCCS 1.0 (2019) [M+Na]+ 114.7097618 predictedDarkChem Lite v0.1.0 [M+Na]+ 114.7461618 predictedDarkChem Lite v0.1.0 [M+Na]+ 136.7252 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsAlcohol dehydrogenase 1B
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Zinc ion binding
- Specific Function
- Not Available
- Gene Name
- ADH1B
- Uniprot ID
- P00325
- Uniprot Name
- Alcohol dehydrogenase 1B
- Molecular Weight
- 39854.21 Da
References
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52